PHACTFYSIO ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  8.1% 26.7% 7.1% 9.2% 8.5%  
Credit score (0-100)  31 3 34 25 28  
Credit rating  B C BB B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  892 673 918 991 895  
Gross profit  592 378 569 622 522  
EBITDA  60.9 230 43.9 174 240  
EBIT  60.9 230 43.9 14.2 195  
Pre-tax profit (PTP)  56.9 227.6 34.4 10.1 194.2  
Net earnings  45.3 227.6 34.4 5.1 194.2  
Pre-tax profit without non-rec. items  56.9 228 34.4 10.1 194  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Tangible assets total  0.0 0.0 190 190 177  
Shareholders equity total  360 110 145 150 344  
Interest-bearing liabilities  0.0 0.0 260 192 94.7  
Balance sheet total (assets)  412 126 468 408 449  

Net Debt  -184 -126 178 9.2 -141  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  892 673 918 991 895  
Net sales growth  -10.7% -24.6% 36.4% 8.0% -9.8%  
Gross profit  592 378 569 622 522  
Gross profit growth  7.2% -36.1% 50.4% 9.2% -16.0%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  412 126 468 408 449  
Balance sheet change%  -44.8% -69.3% 270.2% -12.8% 9.9%  
Added value  60.9 229.6 43.9 14.2 195.5  
Added value %  6.8% 34.1% 4.8% 1.4% 21.8%  
Investments  -190 0 190 -160 -57  

Net sales trend  -1.0 -2.0 1.0 2.0 -1.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
EBITDA %  6.8% 34.1% 4.8% 17.6% 26.8%  
EBIT %  6.8% 34.1% 4.8% 1.4% 21.8%  
EBIT to gross profit (%)  10.3% 60.7% 7.7% 2.3% 37.4%  
Net Earnings %  5.1% 33.8% 3.8% 0.5% 21.7%  
Profit before depreciation and extraordinary items %  5.1% 33.8% 3.8% 16.7% 26.7%  
Pre tax profit less extraordinaries %  6.4% 33.8% 3.8% 1.0% 21.7%  
ROA %  10.5% 85.3% 14.8% 3.2% 45.7%  
ROI %  22.8% 97.6% 17.0% 3.8% 50.1%  
ROE %  17.0% 96.8% 27.0% 3.5% 78.6%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Equity ratio %  87.3% 87.4% 31.0% 36.8% 76.7%  
Relative indebtedness %  5.8% 2.4% 35.2% 26.0% 11.7%  
Relative net indebtedness %  -14.7% -16.4% 26.2% 7.6% -14.7%  
Net int. bear. debt to EBITDA, %  -301.6% -55.1% 404.7% 5.3% -59.0%  
Gearing %  0.0% 0.0% 179.6% 127.9% 27.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 7.3% 1.8% 1.0%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Quick Ratio  7.9 7.9 0.8 0.7 2.3  
Current Ratio  7.9 7.9 0.8 0.7 2.3  
Cash and cash equivalent  183.6 126.4 82.7 182.8 236.2  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  65.5 0.0 63.6 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  46.2% 18.8% 26.4% 18.4% 26.4%  
Net working capital  359.9 110.5 -80.6 -75.5 131.8  
Net working capital %  40.3% 16.4% -8.8% -7.6% 14.7%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 895  
Added value / employee  0 0 0 0 195  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 240  
EBIT / employee  0 0 0 0 195  
Net earnings / employee  0 0 0 0 194